E-cigarette Not Effective in Helping Quit Smoking: Expert Warns

Industry Insight by 2FIRSTS.ai
Mar.08.2024
E-cigarette Not Effective in Helping Quit Smoking: Expert Warns
Agus Dwi Susanto, a professor at an Indonesian medical school, warns against the limited effectiveness of e-cigarettes in quitting smoking.

According to a report by ANTARA on March 7th, Professor Agus Dwi Susanto, a specialist in pulmonary and respiratory medicine at a university in Indonesia, stated that while e-cigarettes can help people quit smoking to some extent, they do not truly help users kick the habit.

 

Professor Agus's views come from a response to a video on the social media platform TikTok, which details the process of how a regular e-cigarette user eventually developed pneumonia. In the interview, Professor Agus emphasized that:

 

Following the World Health Organization's (WHO) standard operating procedure (SOP) for smoking cessation is crucial. This procedure requires users to completely quit smoking after completing medication therapy as advised by a doctor.

 

However, the reality is often that although many people have stopped traditional smoking, they continue to use e-cigarettes. Professor Agus is deeply saddened by this, as he believes: "This situation indicates that e-cigarettes have not been properly viewed as a part of smoking cessation therapy, but rather as a switch from traditional cigarettes to e-cigarettes."

 

Therefore, Professor Agu urges the public to reassess the relationship between e-cigarettes and their effectiveness in quitting smoking. He warns, "Traditional tobacco products, e-cigarettes, or hookahs all pose a threat to health in the same way. We must avoid using these products, as they all have the potential to cause serious health problems."

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Ohio Appeals Court Upholds Dismissal of Lawsuit Against E-Cigarette Retailer, Deepening State-Federal Regulatory Dispute
Ohio Appeals Court Upholds Dismissal of Lawsuit Against E-Cigarette Retailer, Deepening State-Federal Regulatory Dispute
Ohio Appeals Court Rejects State Attorney General's Lawsuit Against E-Cigarette Retailer, Emphasizing FDA Regulatory Authority.
Oct.15 by 2FIRSTS.ai
ZYN’s Trademark Dilemma in China | Legal Opinion Submitted to 2Firsts
ZYN’s Trademark Dilemma in China | Legal Opinion Submitted to 2Firsts
ZYN faces trademark revocation and enforcement challenges in China. In this legal commentary submitted to 2Firsts, the author examines regulatory gaps, enforcement hurdles, and the high legal risks surrounding nicotine pouch trademarks.
Oct.14
Imperial Brands FY25 Results: NGP Net Revenue Up 13.7%, Americas Surges Nearly 70%
Imperial Brands FY25 Results: NGP Net Revenue Up 13.7%, Americas Surges Nearly 70%
Imperial Brands reported FY25 NGP net revenue of £368 million, up 13.7% at constant currency. Growth in the Americas accelerated sharply, with NGP revenue up 69.8%, driven by the expansion of the modern oral brand Zone. Europe delivered 8.8% growth, supported by blu’s double-digit vapour share across key markets. Adjusted NGP operating losses narrowed to £76 million, putting the category closer to breakeven.
Nov.18 by 2FIRSTS.ai
Malaysia Collected US$50.07 million in Vape Tax Since April 2023
Malaysia Collected US$50.07 million in Vape Tax Since April 2023
Malaysia collected RM209.5 million(US$50.07 million) in excise duty on nicotine-containing vape liquids and gels from April 2023 to August 2025, according to Finance Ministry data. However, Health Minister Dr Dzulkefly Ahmad said RM223.5 million was spent treating EVALI patients in the past year alone, exceeding the tax revenue.
Nov.06 by 2FIRSTS.ai
KT&G Q3 Net Profit Up 73%; Overseas NGP Revenue Nearly Doubles, Nicotine Pouch Expansion Set to Launch Globally
KT&G Q3 Net Profit Up 73%; Overseas NGP Revenue Nearly Doubles, Nicotine Pouch Expansion Set to Launch Globally
KT&G reported its Q3 2025 financial results, posting revenue of KRW 1.83 trillion (≈USD 1.31 billion) and a 73.4% year-over-year surge in net profit—marking the company’s highest operating profit in five years. The Next Generation Product (NGP) segment performed strongly, generating KRW 279.1 billion (≈USD 199 million) in revenue, with overseas NGP sales more than doubling year-over-year.
Nov.06
CSUR, the Research Institute Supporting Juul’s PMTA Research, Outlines a New Pathway for Nicotine Pouches
CSUR, the Research Institute Supporting Juul’s PMTA Research, Outlines a New Pathway for Nicotine Pouches
CSUR—the Research Institute Supporting Juul and NJOY’s successful PMTAs—assessed FDA’s pilot for nicotine pouches. The program expedites premarket review by deferring behavioral data to post-market reporting. CSUR says this could speed authorizations, but manufacturers must still produce behavioral and real-world evidence after a Marketing Granted Order to maintain compliance with public-health standards.
Nov.04